Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Chinese Real-world Study of Rimegepant for the Acute Treatment of Migraine

NCT06439628 is registered in ClinicalTrials.gov with Chinese PLA General Hospital as lead sponsor.

NCT NCT06439628
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06439628 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Chinese Real-world Study of Rimegepant for the Acute Treatment of Migraine
Lead sponsor
Chinese PLA General Hospital
Phase
Observational
Overall status
Active, not recruiting
Start date
August 27, 2024
Completion date
June 28, 2027
Enrollment
3,000 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

migraine